Arca
Skip to content

Mental health concerns

Drug research and approvals for mental health concerns: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 6 studies of mental health concerns are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.

  • Recruiting worldwide: 6
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 6 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jul 31, 2025Psilocybin microdose for psychchological and existential distress in palliative care (psyched-pal): a multi-site phase 3 double-blind, placebo-controlled,…PSILOCYBINBRUYÈRE HEALTH RESEARCH INSTITUTEOngoing
Jan 14, 2025Evaluating the effect of psilocybin-assisted group therapy on indicators of wellness in well and unwell individualsPSILOCYBIN (PEX010)16506607 CANADA INCPending
Jul 26, 2024Examining the impact 3,4-methylenedioxymethamphetamine assisted group therapy on measures of wellness: a pilot study isa 4-7METHYLENEDIOXYMETHAMPHETAMINE (MDMA)GAURAV GUPTAPending
Feb 21, 2024Gathering group's study to examine the impact of psilocybin (4-phosphoryloxy-n,n-dimethyltryptamine) in assisted group therapy on measures of wellness.PSILOCYBINGATHERING RESILIENCE GROUPS INCORPORATEDPending
Jan 17, 2024Conscious mind's study to examine the impact of psilocybin (4-phosphoryloxy-n,n-dimethyltryptamine) in assisted group therapy on measures of wellness.PSILOCYBINCONSCIOUS MIND CLINICPending
Nov 23, 2023A phase II study assessing the efficacy of mdma when administered to frontline healthcare workers with mental health concernsMETHYLENEDIOXYMETHAMPHETAMINE (MDMA)ATMA JOURNEY CENTRESPending
Jan 27, 2023A master protocol to examine the impact of psilocybin (4-phosphoryloxy-n,ndimethyltryptamine) in assisted group therapy on measures of wellnessPSILOCYBINGAURAV GUPTAPending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.